Search Results for: Regimen

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen (Delamanid, Linezolid, Levofloxacin, Pyrazinamide) in Korean Patients with Fluoroquinolone-Sensitive Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) : a Non-interventional, Prospective Observational Study (MDR-END Registry)

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen (Delamanid, Linezolid, Levofloxacin, Pyrazinamide) in Korean Patients with Fluoroquinolone-Sensitive Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) : a Non-interventional, Prospective Observational Study (MDR-END Registry)

Tuberculosis News
Publication date: Nov 03, 2024 This study is to evaluate the effectiveness and safety of a 9-month MDR-END regimen as a treatment for fluoroquinolone-sensitive multidrug resistant pulmonary tuberculosis in the ... Read more
Treatment of acute myeloid leukemia with active pulmonary tuberculosis with venetoclax-based anti-acute myeloid leukemia regimen combined with an intensive and then individualized anti-tuberculosis regimen: A report of two cases.

Treatment of acute myeloid leukemia with active pulmonary tuberculosis with venetoclax-based anti-acute myeloid leukemia regimen combined with an intensive and then individualized anti-tuberculosis regimen: A report of two cases.

Tuberculosis Literature
Publication date: Dec 01, 2024 Patients with concurrent acute myeloid leukemia (AML) and active pulmonary tuberculosis (TB) exhibit certain characteristics; cough, phlegm, fever, hemoptysis, weight loss and dyspnea are common ... Read more